Codiak BioSciences Inc. (CDAK) Social Stream
CODIAK BIOSCIENCES INC (CDAK) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CDAK.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 2 | $34 | $34 | $34 | $0.174 | 19440.23% |
| 2022-02-22 | 2 | $24 | $24 | $24 | $0.174 | 13693.1% |
| 2022-05-06 | 2 | $17 | $17 | $17 | $0.174 | 9670.11% |
| 2022-05-24 | 3 | $17 | $8 | $12.5 | $0.174 | 7083.91% |
| 2022-07-05 | 3 | $17 | $7 | $12 | $0.174 | 6796.55% |
| 2022-08-05 | 3 | $9 | $7 | $8 | $0.174 | 4497.7% |
| 2022-11-04 | 3 | $7 | $2 | $4.5 | $0.174 | 2486.21% |
| 2022-11-07 | 1 | $1.4 | $1.4 | $1.4 | $0.174 | 704.6% |
Price Target Last Issued November 7, 2022
The Trend in the Analyst Price Target
Over the past 20 months, CDAK's average price target has gone down $30.8.
Over the past 26 weeks, CDAK's average upside potential has been 353.21%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-07-05 | 3 | 17.0 | 7.0 | 12.0 | 2.880 | 316.67% |
| 2022-09-01 | 3 | 7.0 | 2.0 | 4.5 | 1.740 | 158.62% |
| 2022-11-04 | 3 | 7.0 | 2.0 | 4.5 | 0.720 | 525% |
| 2022-11-07 | 3 | 1.4 | 1.4 | 1.4 | 0.798 | 75.44% |
| 2022-11-07 | 1 | 1.4 | 1.4 | 1.4 | 0.798 | 75.44% |
CDAK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 1 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 61 days, CDAK's average broker recommendation rating worsened by 0.33.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CDAK as an investment opportunity.
- CDAK has a higher upside potential (average analyst target price relative to current price) than 1090.91% of all US stocks.
- CDAK has a higher number of analysts covering the stock than 70.13% of all US stocks.
- In the context of stocks in the small market cap category, CODIAK BIOSCIENCES INC's variance in analysts' estimates is lower than -284.66% of them.
- CDAK has a higher average analyst price target than 260.25% of Healthcare stocks.
In the Pharmaceutical Products industry, OPT, TARS, and ALGS are the three stocks most similar to CODIAK BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is CDAK a Buy, Hold or Sell? See the POWR Ratings now!